Search
Selected Filter
Displaying 21–30 of 152 news results
-
The Foundation in the News
On World Sight Day 2022, Retina International is presenting data from a report on its study into the Socio-economic Impact of late-stage age-related macular degeneration (AMD) in Bulgaria, Germany, and USA.
-
Eye on the Cure Podcast – Episode 33: Jacque Duncan, MD
Foundation PodcastsOctober 7, 2022. Ben Shaberman talks with Jacque Duncan, MD.
-
Press Releases
Initiatives to increase engagement and awareness around blinding retinal diseases.
-
RD Fund Participates in a €75 Million Series B for SparingVision
The Foundation in the NewsProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Foundation Fighting Blindness Makes Key Appointments to Leadership Team
Press ReleasesSeveral executives promoted to continue the advancement of the Foundation’s notable research and philanthropic efforts.
-
Foundation Insights Forum – August 12, 2022
Insights ForumThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on August 12, 2022.
-
Progress toward a stem cell–based therapy for blindness
The Foundation in the NewsA multi-institutional effort led by researchers at the School of Veterinary Medicine is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
-
RD Fund Announces New Chair, and Expansion of Board of Directors
The Foundation in the NewsRD Fund Board member and seasoned ophthalmology leader Adrienne Graves, PhD, appointed chair. Ophthalmology luminaries Jean Bennett, MD, PhD, Catherine Bowes Rickman, PhD, and José-Alain Sahel, MD, to join the board.
-
Foundation Fighting Blindness Announces Leadership Changes
Press ReleasesJason Menzo named chief executive officer • Russell Kelley, PhD, MBA, appointed managing director of the RD Fund • Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company.
-
The Foundation in the News
Funds to support advancement of two clinical trials through proof of concept: NPI-001 for retinitis pigmentosa in Usher syndrome and NPI-002 to slow cataract progression.
%20(1).png)
